Bionow | News

Centauri Therapeutics awarded £1M grant under new PACE programme to advance imm...

Dec 23rd 2024

Centauri Therapeutics Limited (Centauri), an immunotherapy company with a unique and proprietary platform technology applicable across a wide range of therapeutic indications has been awarde...

Myricx Bio announces £90m ($114m) Series A financing to advance its novel NMTi-...

Jul 8th 2024

Myricx Bio, a UK biotech company focusing on the discovery and development of a completely novel class of payloads for antibody-drug conjugates (ADCs), today announced the closing of its Ser...

AMPLY Discovery raises £1.4m in Innovate UK grant funding to tackle complex dis...

Feb 20th 2024

Belfast-based techbio company AMPLY Discovery Limited has raised over £1.4m in grant funding to develop new drug products using its proprietary AI-driven drug discovery platform.

Cresset June 2022 newsletter

Jun 28th 2022

A roundup of computational chemistry news from Cresset in June.

Introduction to Factorytalk podcast with Growth Platform

Feb 17th 2021

Neil Wetherall, UK MD joined the podcast interview with Growth Platform talks, Liverpool City Regions. Hear how we are shaping pharmaceutical manufacturing using industry 4.0 methodology.

Government funding boost for COVID-19 drug testing platform

Feb 16th 2021

The COVID-19 drug testing platform AGILE, co-led by the University of Liverpool, has received a multi-million pound award from the UK government’s Department of Health and Social Care to f...

Strategic reproductive health partnership secured in Japan

Oct 8th 2020

Yourgene Health (AIM: YGEN), a leading international molecular diagnostics group, announces it has entered into a 5-year strategic partnership with a blue chip Japanese multinational to prov...

Viva Biotech and SYNthesis Enters a Strategic Acquisition Agreement

Sep 22nd 2020

Viva Biotech and SYNthesis Enters a Strategic Acquisition Agreement, Accelerating the Development of Global Innovative Drug R & D Service Capabilities

Innovative COVID-19 drug testing platform launched

Jul 9th 2020

The University of Liverpool, Liverpool School of Tropical Medicine and Southampton Clinical Trials Unit have announced the launch of an innovative COVID-19 drug testing platform, AGILE.

Biorelate offers free access to AI-based drug discovery tool: Galactic

May 27th 2020

Biorelate, a UK-based AI start up, is offering all researchers free use of Galactic, its cloud-based web tool, to support biomedical research while lab access is restricted around the world.

RSM Coronavirus Hub - Insights, advice and support

Apr 3rd 2020

The coronavirus pandemic is causing disruption and uncertainty across the globe and businesses are facing many challenges. As the Government continues to announce support and advice, we will...

Repositive makes world-leading directory of 5,300 preclinical cancer models publ...

Jul 22nd 2019

Repositive has made its world-leading directory of preclinical cancer models publicly browsable as the first stage of relaunching its Cancer Models Platform. Accessible via the Repositive we...

News